(Q51542242)

6 April 2018

title

Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. (English)

1 reference

6 April 2018

author name string

Sanaul Mustafa

series ordinal

1

1 reference

6 April 2018

V Kusum Devi

series ordinal

2

1 reference

6 April 2018

Roopa S Pai

series ordinal

3

1 reference

6 April 2018

publication date

30 August 2016

1 reference

6 April 2018

Drug delivery and translational research

published in

1 reference

6 April 2018

volume

7

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

27-36

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s13346-016-0326-7

exact match

0 references

cites work

Nanocarrier-based interventions for the management of MDR/XDR-TB.

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Drug resistance in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

BDDCS applied to over 900 drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Moxifloxacin-induced acute liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Polysaccharide-decorated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Chitosan and its use as a pharmaceutical excipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

The effect of physical barriers and properties on the oral absorption of particulates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-016-0326-7

Analysis of the interferences in quantitation of a site-specifically PEGylated exendin-4 analog by the Bradford method

21 January 2018

1 reference

12 December 2020

Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential

1 reference

12 December 2020

Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process

1 reference

12 December 2020

PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution

1 reference

12 December 2020

Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma

1 reference

12 December 2020

Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles

1 reference

12 December 2020

Preparation and physical characterization of a novel marine oil emulsion as a potential new formulation vehicle for lipid soluble drugs

1 reference

12 December 2020

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis

1 reference

12 December 2020

10.1007/S13346-016-0326-7

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

27576453

1 reference

6 April 2018